Association between glutathione S-transferases M1 and T1 gene polymorphisms and prostate cancer risk: A systematic review and meta-analysis

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 247-256

  Cai, Qiliang ^a   Wang, Zhun ^a   Zhang, Wei ^a   Guo, Xuemei ^b   Shang, Zhiqun ^a   Jiang, Ning ^a   Tian, Jing ^a   Niu, Yuanjie ^a  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Glutathione S transferases M1; Glutathione S transferases T1 polymorphism; Meta analysis; Molecular epidemiology; Prostate cancer

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

AFRICAN AMERICAN; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CAUCASIAN; DATA EXTRACTION; DISEASE ASSOCIATION; DNA POLYMORPHISM; EMBASE; GENOTYPE; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PUBLISHING; QUALITY CONTROL; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; PUBLICATION BIAS; RISK;

EID: 84893757022     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1030-6     Document Type: Article

References (35)

1. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer. 2000;85:60-7.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin. 2010;60:277-300.
3. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics. CA Cancer J Clin. 2011;61:212-36.
4. Autrup JL, Thomassen LH, Olsen JH, Wolf H, Autrup H. Glutathione S-transferases as risk factors in prostate cancer. Eur J Cancer Prev. 1999;8:525-832.
5. Kote-Jarai Z, Easton D, Edwards SM, Jefferies S, Durocher F, Jackson RA, et al. Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics. 2001;11:325-30.
6. Medeiros R, Vasconcelos A, Costa S, Pinto D, Ferreira P, Lobo F, et al. Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms. Prostate. 2004;58:414-20.
7. Joseph MA, Moysich KB, Freudenheim JL, Shields PG, Bowman ED, Zhang Y, et al. Ambrosone cruciferous vegetables, genetic polymorphisms in glutathione S-transferases m1 and t1, and prostate cancer risk. Nutr Cancer. 2004;50:206-13.
8. Komiya Y, Tsukino H, Nakao H, Kuroda Y, Imai H, Katoh T. Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population. J Cancer Res Clin Oncol. 2005;131:238-42.
9. Caceres DD, Iturrieta J, Acevedo C, Huidobro C, Varela N, Quinones L. Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene-gene and gene-environment interactions. Eur J Epidemiol. 2005;20:79-88.
10. Guan TY, Li M, Na YQ. Polymorphism of metabolic gene and genetic susceptibility to prostate cancer. Chin J Surg. 2005;43:1467-70.
11. Lai MT, Chen RH, Tsai FJ, Wan L, Chen WC. Glutathione S-transferase M1 gene but not insulin-like growth factor-2 gene or epidermal growth factor gene is associated with prostate cancer. Urol Oncol. 2005;23:225-9.
12. Agalliu I, Langeberg WJ, Lampe JW, Salinas CA, Stanford JL. Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle-aged men. Prostate. 2006;66:146-56.
13. Lavender NA, Benford ML, VanCleave TT, Brock GN, Kittles RA, Moore JH, et al. Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among men of African descent: a case-control study. BMC Cancer. 2009;9:397.
14. Sivoňová M, Waczulíková I, Dobrota D, Matáková T, Hatok J, Račay P, et al. Polymorphisms of glutathione-S-transferase M1, T1, P1 and the risk of prostate cancer: a case-control study. J Exp Clin Cancer Res. 2009;28:32-40.
15. Souiden Y, Mahdouani M, Chaieb K, Elkamel R, Mahdouani K. Polymorphisms of glutathione-S-transferase M1 and T1 and prostate cancer risk in a Tunisian population. Cancer Epidemiol. 2010;34:598-603.
16. Ansari SB, Vasudevan R, Bakhshi A, Mirinargesi M, Patimah I, Sabariah AR, et al. Analysis of glutathione S-transferase (M1, T1 and P1) gene polymorphisms in Iranian prostate cancer subjects. Afr J Biotechnol. 2010;9(43):7230-5.
17. Kumar V, Yadav CS, Datta SK, Singh S, Ahmed RS, Goel S, et al. Association of GSTM1 and GSTT1 polymorphism with lipid peroxidation in benign prostate hyperplasia and prostate cancer: a pilot study. Dis Markers. 2011;30:163-9.
18. Safarinejad MR, Shafiei N, Safarinejad SH. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran. Prostate Cancer Prostatic Dis. 2011;14:105-13.
19. Ashtiani ZO, Hasheminasab SM, Ayati M, Goulian BS, Modarressi MH. Are GSTM1, GSTT1 and CAG repeat length of androgen receptor gene polymorphisms associated with risk of prostate cancer in Iranian patients? Pathol Oncol Res. 2011;17:269-75.
20. Kwon DD, Lee JW, Han DY, Seo IY, Park SC, Jeong HJ, et al. Relationship between the glutathione-S-transferase P1, M1, and T1 genotypes and prostate cancer risk in Korean subjects. Korean J Urol. 2011;52:247-52.
21. Thakur H, Gupta L, Sobti RC, Janmeja AK, Seth A, Singh SK. Association of GSTM1T1 genes with COPD and prostate cancer in north Indian population. Mol Biol Rep. 2011;38:1733-9.
22. Mo Z, Gao Y, Cao Y, Gao F, Jian L. An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review. Prostate. 2009;69:662-88.
23. Mittal RD, Kesarwani P, Singh R, Ahirwar D, Mandhani A. GSTM1, GSTM3 and GSTT1 gene variants and risk of benign prostate hyperplasia in North India. Dis Markers. 2009;26:85-91.
24. Konwar R, Manchanda PK, Chaudhary P, Nayak VL, Singh V, Bid HK. Glutathione S-transferase gene variants and risk of benign prostate hyperplasia in a North Indian population. Asian Pac J Cancer Prev. 2010;11(2):365-70.
25. Konwar R, Manchanda PK, Chaudhary P, Nayak VL, Singh V, Bid HK. Glutathione S-transferase (GST) gene variants and risk of benign prostatic hyperplasia: a report in a North Indian population. Asian Pac J Cancer Prev. 2010;11(4):1067-72.
26. Wei BB, Xu ZQ, Zhou Y, Ruan J, Cheng H, Xi B, et al. Association of GSTM1 null allele with prostate cancer risk: evidence from 36 case-control studies. PLoS One. 2012;7(10):e46982.
27. Ntais C, Polycarpou A, Ioannidis JPA. Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomark Prev. 2011;14(1):176-81.
28. Zintzaras E, Ioannidis JP. HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics. 2005;21:3672-3.
29. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
30. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820-6.
31. Zintzaras E, Chatzoulis DZ, Karabatsas CH, Stefanidis I. The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J Hum Genet. 2005;50:267-75.
32. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101.
33. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
34. Fleiss JL, Tytun A, Uray HK. A simple approximation for calculating sample size for comparing independent proportions. Biometrics. 1980;36:343-6.
35. Warholm M, Guthenberg C, Mannervik B. Molecular and catalytic properties of glutathione transferase mu from human liver: an enzyme efficiently conjugating epoxides. Biochemistry.1983;22(15):3610-17.